Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies.
Hallek M. Hallek M. Hematology Am Soc Hematol Educ Program. 2013;2013:138-50. doi: 10.1182/asheducation-2013.1.138. Hematology Am Soc Hematol Educ Program. 2013. PMID: 24319175 Review.
The management of chronic lymphocytic leukemia (CLL) is undergoing profound changes. Several new drugs have been approved for CLL treatment (fludarabine, bendamustine, and the monoclonal antibodies alemtuzumab, rituximab, and ofatumumab) and man …
The management of chronic lymphocytic leukemia (CLL) is undergoing profound changes. Several new drugs have been …
Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies.
Hallek M. Hallek M. Blood. 2013 Nov 28;122(23):3723-34. doi: 10.1182/blood-2013-05-498287. Epub 2013 Sep 24. Blood. 2013. PMID: 24065239 Review.
The management of chronic lymphocytic leukemia (CLL) is undergoing profound changes. Several new drugs have been approved for CLL treatment (fludarabine, bendamustine, and the monoclonal antibodies alemtuzumab, rituximab, and ofatumumab) and man …
The management of chronic lymphocytic leukemia (CLL) is undergoing profound changes. Several new drugs have been …
Hallek M. Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies. Hematology Am Soc Hematol Educ Program. 2013;2013:138-150.
[No authors listed] [No authors listed] Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):604. doi: 10.1182/asheducation-2014.1.604. Epub 2014 Nov 18. Hematology Am Soc Hematol Educ Program. 2014. PMID: 25696918 No abstract available.
Feedback